IGF2 and neoplasm: In addition to these, the accumulation of CAFs in tumor tissues can promote drug resistance by inducing the expression of insulin-like growth factor 2 (IGF2) and insulin-like growth factor receptor-1 (IGF-1R) signaling, which leads to P-glycoprotein expression and increased drug efflux [169].